Mc Gee, Lawrence R. Litigation, Intellectual Property, Attorneys, SEC Filings, and Other Public Records

Add a document

Date Recorded	Party	Role	Document Type	Document No.	Invention Title

8/17/2021	Oric Pharmaceuticals, Inc.	Assignee	Application Publication	17404493 20210395295	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

7/21/2021	Oric Pharmaceuticals, Inc.	Assignee	Application Publication	17381430 20210379084	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

9/30/2020	Oric Pharmaceuticals, Inc.	Assignee	Application Publication	17039794 20210017219	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

9/25/2020	R2m Pharma, Inc.	Assignee	Application Publication Patent	16926536 20210163402 11319280	Opioid Receptor Modulators And Products And Methods Related Thereto

6/2/2020	Oric Pharmaceuticals, Inc.	Assignee	Application Publication Patent	16889624 20200291058 10836789	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

9/5/2019	Oric Pharmaceuticals, Inc.	Assignee	Application Publication Patent	16562204 20200055892 10723759	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/9/2019	Oric Pharmaceuticals, Inc.	Assignee	Application Publication	16365422 20190218246	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/9/2019	Oric Pharmaceuticals, Inc.	Assignee	Application Publication Patent	16365422 20190218246 10472387	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/24/2018	Oric Pharmaceuticals, Inc.	Assignee	Application Publication	16065627 20210002324	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/24/2018	Oric Pharmaceuticals, Inc.	Assignee	Application Publication	16065626 20210017220	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/24/2018	Oric Pharmaceuticals, Inc.	Assignee	Application Publication	16065625 20210023095	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/24/2018	Oric Pharmaceuticals, Inc.	Assignee	Application Publication Patent	16065625 20210023095 11110103	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/24/2018	Oric Pharmaceuticals, Inc.	Assignee	Application Publication Patent	16065626 20210017220 11124537	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/24/2018	Oric Pharmaceuticals, Inc.	Assignee	Application Publication Patent	16065627 20210002324 11208432	Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor Inhibitors Of Glucocorticoid Receptor

8/4/2016	Amgen Inc.	Assignee	Application Publication	15158174 20160340336	Triazole Agonists Of The Apj Receptor Triazole Agonists Of The Apj Receptor

8/4/2016	Amgen Inc.	Assignee	Application Publication Application	15158174 20160340336 9573936	Triazole Agonists Of The Apj Receptor Triazole Agonists Of The Apj Receptor

6/10/2016	Amgen Inc.	Assignee	Application Publication	14760978 20150353542	Methods Of Using Cell-cycle Inhibitors To Modulate One Or More Propertie... Methods Of Using Cell-cycle Inhibitors To Modulate One Or More Propertie...

4/9/2015	Amgen Inc.	Assignee	Application Publication Patent	14301087 20140364455 9376386	Techniques For Activating Single Wire Communications Processes Of Making And Crystalline Forms Of A Mdm2 Inhibitor Processes Of Making And Crystalline Forms Of A Mdm2 Inhibitor

6/24/2014	Amgen Inc.	Assignee	Application Publication	14103418 20140199728	Methods Of Using Cell-cycle Inhibitors To Modulate One Or More Propertie... Methods Of Using Cell-cycle Inhibitors To Modulate One Or More Propertie...

6/12/2012	Amgen Inc.	Assignee	Application Publication Patent	13425817 20120244110 8623885	Fused Tricyclic Dual Inhibitors Of Cdk 4/6 And Flt3 Fused Tricyclic Dual Inhibitors Of Cdk 4/6 And Flt3 Method And Apparatus For Measuring Speed Of A Brush Motor

1/13/2011	Amgen Inc.	Assignee	Application Publication	12997868 20110086834	Alkynyl Alcohols As Kinase Inhibitors Alkynyl Alcohols As Kinase Inhibitors

11/22/2010	Amgen Inc.	Assignee	Application Publication Patent	12936725 20110097305 8389533	Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Cell Cy... Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Cell Cy... Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Cell Cy...

10/28/2010	Amgen Inc.	Assignee	Application Publication Patent	12808621 20110142796 8841312	Fused Pyridine, Pyrimidine And Triazine Compounds As Cell Cycle Inhibito... Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibito... Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibito...

5/1/2009	Gilead Sciences, Inc.	Assignee	Application Publication	12211745 20090149648	Nucleotide Analogs Nucleotide Analogs

5/28/2008	Amgen Inc.	Assignee	Application Publication Patent	12079406 20090137581 8193199	Heterocyclic Compounds And Their Uses Heterocyclic Compounds And Their Uses Heterocyclic Compounds And Their Uses

10/2/2007	Gilead Sciences, Inc.	Assignee	Application Patent	08617849 5798340	Nucleotide Analogs Nucleotide Analogs

12/23/2005	Amgen Inc.	Assignee	Application Publication Patent	11203006 20060084802 7544702	Bisaryl-sulfonamides Bisaryl-sulfonamides Bisaryl-sulfonamides

10/9/2001	Tularik Inc.	Assignee	Application Publication Patent	09894980 20020169185 6583157	Quinolinyl And Benzothiazolyl Modulators Quinolinyl And Benzothiazolyl Modulators Quinolinyl And Benzothiazolyl Modulators

8/27/2001	Gilead Sciences, Inc.	Assignee	Application Publication	09740504 20020058823	Preparation of cyclohexene carboxylate derivatives Preparation of cyclohexene carboxylate derivatives

12/1/2000	Tularik Inc.	Assignee	Application Patent	09606433 7041691	Compounds For The Modulation Of Ppary Activity Compounds For The Modulation Of Ppary Activity

5/10/2000	Gilead Sciences, Inc.	Assignee	Application Patent	09242119 6204398	Preparation Of Cyclohexene Carboxylate Derivatives Preparation Of Cyclohexene Carboxylate Derivatives

4/5/2000	Tularik Inc.	Assignee	Application Patent	09234327 6200995	Ppar-gamma Modulators Ppar-gamma Modulators

12/18/1997	Gilead Sciences, Inc.	Assignee	Application Patent	08917640 5886213	Preparation Of Carbocyclic Compounds Preparation Of Carbocyclic Compounds

5/19/1997	Gilead Sciences, Inc.	Assignee	Application Patent	08740568 5811450	Thiepane Compounds Thiepane Compounds

4/28/1997	Gilead Sciences, Inc.	Assignee	Application Patent	08123483 5656745	Nucleotide Analogs Nucleotide Analogs

4/28/1997	Gilead Sciences, Inc.	Assignee	Application Patent	08701942 5859284	Preparation Of Carbocyclic Compounds Preparation Of Carbocyclic Compounds

12/16/1996	Gilead Sciences, Inc.	Assignee	Application Patent	08740568 5811450	Thiepane Compounds Thiepane Compounds

10/21/1996	Gilead Sciences, Inc.	Assignee	Application Patent	08701942 5859284	Preparation Of Carbocyclic Compounds Preparation Of Carbocyclic Compounds

7/12/1996	Gilead Sciences, Inc.	Assignee	Application Patent	08617849 5798340	Nucleotide Analogs Nucleotide Analogs

2/23/1996	Gilead Sciences, Inc.	Assignee	Application Patent	08552429 6034118	Thiepane Compounds Thiepane Compounds

7/24/1995	Gilead Sciences, Inc.	Assignee	Application Patent	08473876 5705524	Thiepane Compounds Thiepane Compounds

9/17/1993	Gilead Sciences, Inc.	Assignee	Application Patent	08123483 5656745	Nucleotide Analogs Nucleotide Analogs

11/15/1991	Du Pont Merck Pharmaceutical Company	Assignee	Application Patent	07714042 5294720	1,4-diamino-2,3-dihydroxybutanes 1,4-diamino-2,3-dihydroxybutanes

43 Rows Total

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.